Role of EGF receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes

Hiroaki Kodama, Keiichi Fukuda, Toshiyuki Takahashi, Motoaki Sano, Takahiro Kato, Satoko Tahara, Daihiko Hakuno, Toshihiko Sato, Tomohiro Manabe, Fusako Konishi, Satoshi Ogawa

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

G protein-coupled receptor (GPCR)-evoked signal transduction pathways leading to the activation of extracellular signal-regulated kinases (ERK) are quite different among cell types. In cardiomyocytes, much attention has been focused on the activation of protein kinase C (PKC) or mobilization of intracellular Ca2+ ([Ca2+]i), however, the contributions of tyrosine kinases are controversial. In the present study, we characterized the signaling pathways involving tyrosine kinases, Pyk2 and epidermal growth factor receptor (EGFR), and their contribution to ERK activation in cultured cardiomyocytes. We initially investigated the potential involvement of [Ca2+]i and PKC on the activation of these kinases in endothelin-stimulated cardiomyocytes. Interestingly, activation of Pyk2 was abrogated by chelating [Ca2+]i or by downregulation of PKC, whereas transactivation of EGFR was solely dependent on PKC. By using a compound that selectively interferes with EGFR (AG1478), c-Src (PP1), or disrupts actin cytoskeleton (cytochalasin D), we demonstrated that cytochalasin D completely inhibited the activation of Pyk2, but not that of EGFR, whereas AG1478 did not inhibit the activation of Pyk2, indicating that transactivation of EGFR and signaling pathways involving Pyk2 were distinct pathways. Furthermore, activation of ERK and Shc, and c-fos gene expression were significantly inhibited by AG1478 but not by cytochalasin D or PP1. Overexpression of deletion mutant of EGFR attenuated the activation of ERK. These facts demonstrated the existence of two distinct tyrosine kinase pathways requiring Pyk2 or EGFR downstream from GPCR in cardiomyocytes. EGFR was Ca2+-independently activated and predominantly contributed to Shc/ERK/c-fos activation, while Pyk2 or c-Src contributed less to it.

Original languageEnglish
Pages (from-to)139-150
Number of pages12
JournalJournal of Molecular and Cellular Cardiology
Volume34
Issue number2
DOIs
Publication statusPublished - 2002 Feb 1

Fingerprint

Extracellular Signal-Regulated MAP Kinases
Endothelin-1
Epidermal Growth Factor Receptor
Cardiac Myocytes
Cytochalasin D
Protein Kinase C
Protein-Tyrosine Kinases
G-Protein-Coupled Receptors
Transcriptional Activation
fos Genes
Endothelins
Actin Cytoskeleton
Signal Transduction
Phosphotransferases
Down-Regulation
Gene Expression

Keywords

  • c-Src
  • Cardiac hypertrophy
  • Endothelin-1
  • Epidermal growth factor receptor
  • Extracellular signal regulated kinase
  • Pyk2
  • Signal transduction

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Role of EGF receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes. / Kodama, Hiroaki; Fukuda, Keiichi; Takahashi, Toshiyuki; Sano, Motoaki; Kato, Takahiro; Tahara, Satoko; Hakuno, Daihiko; Sato, Toshihiko; Manabe, Tomohiro; Konishi, Fusako; Ogawa, Satoshi.

In: Journal of Molecular and Cellular Cardiology, Vol. 34, No. 2, 01.02.2002, p. 139-150.

Research output: Contribution to journalArticle

Kodama, Hiroaki ; Fukuda, Keiichi ; Takahashi, Toshiyuki ; Sano, Motoaki ; Kato, Takahiro ; Tahara, Satoko ; Hakuno, Daihiko ; Sato, Toshihiko ; Manabe, Tomohiro ; Konishi, Fusako ; Ogawa, Satoshi. / Role of EGF receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes. In: Journal of Molecular and Cellular Cardiology. 2002 ; Vol. 34, No. 2. pp. 139-150.
@article{fb4e6e8b57cc42579e02778102c0639d,
title = "Role of EGF receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes",
abstract = "G protein-coupled receptor (GPCR)-evoked signal transduction pathways leading to the activation of extracellular signal-regulated kinases (ERK) are quite different among cell types. In cardiomyocytes, much attention has been focused on the activation of protein kinase C (PKC) or mobilization of intracellular Ca2+ ([Ca2+]i), however, the contributions of tyrosine kinases are controversial. In the present study, we characterized the signaling pathways involving tyrosine kinases, Pyk2 and epidermal growth factor receptor (EGFR), and their contribution to ERK activation in cultured cardiomyocytes. We initially investigated the potential involvement of [Ca2+]i and PKC on the activation of these kinases in endothelin-stimulated cardiomyocytes. Interestingly, activation of Pyk2 was abrogated by chelating [Ca2+]i or by downregulation of PKC, whereas transactivation of EGFR was solely dependent on PKC. By using a compound that selectively interferes with EGFR (AG1478), c-Src (PP1), or disrupts actin cytoskeleton (cytochalasin D), we demonstrated that cytochalasin D completely inhibited the activation of Pyk2, but not that of EGFR, whereas AG1478 did not inhibit the activation of Pyk2, indicating that transactivation of EGFR and signaling pathways involving Pyk2 were distinct pathways. Furthermore, activation of ERK and Shc, and c-fos gene expression were significantly inhibited by AG1478 but not by cytochalasin D or PP1. Overexpression of deletion mutant of EGFR attenuated the activation of ERK. These facts demonstrated the existence of two distinct tyrosine kinase pathways requiring Pyk2 or EGFR downstream from GPCR in cardiomyocytes. EGFR was Ca2+-independently activated and predominantly contributed to Shc/ERK/c-fos activation, while Pyk2 or c-Src contributed less to it.",
keywords = "c-Src, Cardiac hypertrophy, Endothelin-1, Epidermal growth factor receptor, Extracellular signal regulated kinase, Pyk2, Signal transduction",
author = "Hiroaki Kodama and Keiichi Fukuda and Toshiyuki Takahashi and Motoaki Sano and Takahiro Kato and Satoko Tahara and Daihiko Hakuno and Toshihiko Sato and Tomohiro Manabe and Fusako Konishi and Satoshi Ogawa",
year = "2002",
month = "2",
day = "1",
doi = "10.1006/jmcc.2001.1496",
language = "English",
volume = "34",
pages = "139--150",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Role of EGF receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes

AU - Kodama, Hiroaki

AU - Fukuda, Keiichi

AU - Takahashi, Toshiyuki

AU - Sano, Motoaki

AU - Kato, Takahiro

AU - Tahara, Satoko

AU - Hakuno, Daihiko

AU - Sato, Toshihiko

AU - Manabe, Tomohiro

AU - Konishi, Fusako

AU - Ogawa, Satoshi

PY - 2002/2/1

Y1 - 2002/2/1

N2 - G protein-coupled receptor (GPCR)-evoked signal transduction pathways leading to the activation of extracellular signal-regulated kinases (ERK) are quite different among cell types. In cardiomyocytes, much attention has been focused on the activation of protein kinase C (PKC) or mobilization of intracellular Ca2+ ([Ca2+]i), however, the contributions of tyrosine kinases are controversial. In the present study, we characterized the signaling pathways involving tyrosine kinases, Pyk2 and epidermal growth factor receptor (EGFR), and their contribution to ERK activation in cultured cardiomyocytes. We initially investigated the potential involvement of [Ca2+]i and PKC on the activation of these kinases in endothelin-stimulated cardiomyocytes. Interestingly, activation of Pyk2 was abrogated by chelating [Ca2+]i or by downregulation of PKC, whereas transactivation of EGFR was solely dependent on PKC. By using a compound that selectively interferes with EGFR (AG1478), c-Src (PP1), or disrupts actin cytoskeleton (cytochalasin D), we demonstrated that cytochalasin D completely inhibited the activation of Pyk2, but not that of EGFR, whereas AG1478 did not inhibit the activation of Pyk2, indicating that transactivation of EGFR and signaling pathways involving Pyk2 were distinct pathways. Furthermore, activation of ERK and Shc, and c-fos gene expression were significantly inhibited by AG1478 but not by cytochalasin D or PP1. Overexpression of deletion mutant of EGFR attenuated the activation of ERK. These facts demonstrated the existence of two distinct tyrosine kinase pathways requiring Pyk2 or EGFR downstream from GPCR in cardiomyocytes. EGFR was Ca2+-independently activated and predominantly contributed to Shc/ERK/c-fos activation, while Pyk2 or c-Src contributed less to it.

AB - G protein-coupled receptor (GPCR)-evoked signal transduction pathways leading to the activation of extracellular signal-regulated kinases (ERK) are quite different among cell types. In cardiomyocytes, much attention has been focused on the activation of protein kinase C (PKC) or mobilization of intracellular Ca2+ ([Ca2+]i), however, the contributions of tyrosine kinases are controversial. In the present study, we characterized the signaling pathways involving tyrosine kinases, Pyk2 and epidermal growth factor receptor (EGFR), and their contribution to ERK activation in cultured cardiomyocytes. We initially investigated the potential involvement of [Ca2+]i and PKC on the activation of these kinases in endothelin-stimulated cardiomyocytes. Interestingly, activation of Pyk2 was abrogated by chelating [Ca2+]i or by downregulation of PKC, whereas transactivation of EGFR was solely dependent on PKC. By using a compound that selectively interferes with EGFR (AG1478), c-Src (PP1), or disrupts actin cytoskeleton (cytochalasin D), we demonstrated that cytochalasin D completely inhibited the activation of Pyk2, but not that of EGFR, whereas AG1478 did not inhibit the activation of Pyk2, indicating that transactivation of EGFR and signaling pathways involving Pyk2 were distinct pathways. Furthermore, activation of ERK and Shc, and c-fos gene expression were significantly inhibited by AG1478 but not by cytochalasin D or PP1. Overexpression of deletion mutant of EGFR attenuated the activation of ERK. These facts demonstrated the existence of two distinct tyrosine kinase pathways requiring Pyk2 or EGFR downstream from GPCR in cardiomyocytes. EGFR was Ca2+-independently activated and predominantly contributed to Shc/ERK/c-fos activation, while Pyk2 or c-Src contributed less to it.

KW - c-Src

KW - Cardiac hypertrophy

KW - Endothelin-1

KW - Epidermal growth factor receptor

KW - Extracellular signal regulated kinase

KW - Pyk2

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=18644364935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18644364935&partnerID=8YFLogxK

U2 - 10.1006/jmcc.2001.1496

DO - 10.1006/jmcc.2001.1496

M3 - Article

VL - 34

SP - 139

EP - 150

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 2

ER -